| References |
1. Li X, Wan L, Wang F, Pei H, Zheng L, Wu W, Ye H, Wang Y, Chen L. Barbigerone reverses multidrug resistance in breast MCF-7/ADR cells. Phytother Res. 2018 Apr;32(4):733-740. doi: 10.1002/ptr.6026. Epub 2018 Jan 24. PubMed PMID: 29368443. 2. Wei Z, Yang Y, Xie C, Li C, Wang G, Ma L, Xiang M, Sun J, Wei Y, Chen L. Synthesis and biological evaluation of pyranoisoflavone derivatives as anti-inflammatory agents. Fitoterapia. 2014 Sep;97:172-83. doi: 10.1016/j.fitote.2014.06.002. Epub 2014 Jun 9. PubMed PMID: 24924289. 3. Wang G, Wang F, Cao D, Liu Y, Zhang R, Ye H, Li X, He L, Yang Z, Ma L, Peng A, Xiang M, Wei Y, Chen L. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents. Bioorg Med Chem Lett. 2014 Jul 15;24(14):3158-63. doi: 10.1016/j.bmcl.2014.04.121. Epub 2014 May 16. PubMed PMID: 24863745. 4. Yang JH, Hu J, Wan L, Chen LJ. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma. Asian Pac J Cancer Prev. 2014;15(1):167-74. PubMed PMID: 24528020. |
